Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan First Pharmaceutical Co., Ltd., originally established as the state-owned Hainan No. 1 Pharmaceutical Factory, is a leading pharmaceutical manufacturer in China. The company is a core subsidiary of the Hainan First Investment Group and focuses on the development, production, and sale of a wide range of chemical drugs. Its product portfolio is particularly strong in anti-infectives, featuring numerous cephalosporin antibiotics in various dosage forms such as freeze-dried powders for injection. The company operates modern, GMP-certified production lines and maintains a significant presence in the domestic Chinese healthcare market. In addition to antibiotics, it produces treatments for cardiovascular and digestive system conditions. The firm is recognized for its robust quality control systems and its role in providing essential generic medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Pharmaceutical Factory No. 1 Pharmaceutical Factory.